Wolfram syndrome 1 is a rare autosomal recessive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Mutations in the WFS1 gene encoding the wolframin glycoprotein can lead to endoplasmic reticulum stress and unfolded protein responses in cells, but the pathophysiology at whole organism level is poorly understood. In this study, several organs (heart, liver, kidneys, and pancreas) and bodily fluids (trunk blood and urine) of 2- and 6-month old Wfs1 knockout (KO), heterozygote (HZ), and wild-type (WT) mice were analyzed by untargeted and targeted metabolomics using liquid chromatography–mass spectrometry. The key findings were significant perturbations in the metabolism of pancreas and heart before the onset of related clinical signs such as glycosuria that precedes hyperglycemia and thus implies a kidney dysfunction before the onset of classical diabetic nephropathy. The glucose use and gluconeogenesis in KO mice are intensified in early stages, but later the energetic needs are mainly covered by lipolysis. Furthermore, in young mice liver and trunk blood hypouricemia, which in time turns to hyperuricemia, was detected. In summary, we show that the metabolism in Wfs1-deficient mice markedly differs from the metabolism of WT mice in many aspects and discuss the future biological and clinical relevance of these observations.
Get full access to this article
View all access options for this article.
References
1.
AnanievaEA, Van HornCG, JonesMR, et al. (2017). Liver BCATm transgenic mouse model reveals the important role of the liver in maintaining BCAA homeostasis. J Nutr Biochem, 40, 132–140.
2.
BarrettTG, BundeySE, and MacleodAF. (1995). Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet, 346, 1458–1463.
3.
BeckonertO, KeunHC, EbbelsTMD, et al. (2007). Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc, 2, 2692–2703.
DescoM-C, AsensiM, MárquezR, et al. (2002). Xanthine oxidase is involved in free radical production in type 1 diabetes. Diabetes, 51, 1118–1124.
6.
DoessingS, HeinemeierKM, HolmL, et al. (2010). Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol, 588, 341–351.
7.
FiehnO. (2002). Metabolomics—The link between genotypes and phenotypes. Plant Mol Biol, 48, 155–171.
8.
FonsecaSG, FukumaM, LipsonKL, et al. (2005). WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic-cells. J Biol Chem, 280, 39609–39615.
9.
FurlongRA, HoLW, RubinszteinJS, et al. (1999). A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases. Neurosci Lett, 277, 123–126.
10.
HofmannS, PhilbrookC, GerbitzK-D, et al. (2003). Wolfram syndrome: Structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet, 12, 2003–2012.
11.
InoueH, TanizawaY, WassonJ, et al. (1998). A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet, 20, 143–148.
12.
IshiharaH. (2004). Disruption of the WFS1 gene in mice causes progressive-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet, 13, 1159–1170.
13.
IvaskM, HugillA, and KõksS. (2016). RNA‐sequencing of WFS1‐deficient pancreatic islets. Physiol Rep, 4, E12750.
14.
KinsleyBT, SwiftM, DumontRH, et al. (1995). Morbidity and mortality in the Wolfram syndrome. Diabetes Care, 18, 1566–1570.
15.
KõksS, PlankenA, LuukH, et al. (2002). Cat odour exposure increases the expression of wolframin gene in the amygdaloid area of rat. Neurosci Lett, 322, 116–120.
16.
KõksS, SoometsU, Paya-CanoJL, et al. (2009). Wfs1 gene deletion causes growth retardation in mice and interferes with the growth hormone pathway. Physiol Genomics, 37, 249–259.
17.
la MarcaG, CasettaB, MalvagiaS, et al. (2006). Implementing tandem mass spectrometry as a routine tool for characterizing the complete purine and pyrimidine metabolic profile in urine samples. J Mass Spectrom, 41, 1442–1452.
18.
LiangX, DickmanMB, and BeckerDF. (2014). Proline biosynthesis is required for endoplasmic reticulum stress tolerance in Saccharomyces cerevisiae. J Biol Chem, 289, 27794–27806.
19.
LuukH, PlaasM, RaudS, et al. (2009). Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav Brain Res, 198, 334–345.
MazzaA, BossoneE, MazzaF, et al. (2005). Reduced serum homocysteine levels in type 2 diabetes. Nutr Metab Cardiovasc Dis, 15, 118–124.
22.
MeigsJB, JacquesPF, SelhubJ, et al. (2001). Fasting plasma homocysteine levels in the insulin resistance syndrome: The Framingham offspring study. Diabetes Care, 24, 1403–1410.
23.
MiddleF, JonesI, McCandlessF, et al. (2000). Bipolar disorder and variation at a common polymorphism (A1832G) within exon 8 of the Wolfram gene. Am J Med Genet, 96, 154–157.
24.
NeumanRE, and LoganMA. (1950). The determination of collagen and elastin in tissues. J Biol Chem, 186, 549–556.
25.
NoormetsK, KõksS, KavakA, et al. (2009). Male mice with deleted Wolframin (Wfs1) gene have reduced fertility. Reprod Biol Endocrinol, 7, 82.
26.
NoormetsK, KõksS, MuldmaaM, et al. (2011). Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp Clin Endocrinol Diabetes, 119, 271–275.
27.
NoormetsK, KõksS, IvaskM, et al. (2014). Energy metabolism and thyroid function of mice with deleted wolframin (Wfs1) gene. Exp Clin Endocrinol Diabetes, 122, 281–286.
28.
PunapartM, EltermaaM, OflijanJ, et al. (2014). Effect of chronic valproic acid treatment on hepatic gene expression profile in wfs1 knockout mouse. PPAR Res, 2014, 349525.
29.
RaudS, SüttS, LuukH, et al. (2009). Relation between increased anxiety and reduced expression of alpha1 and alpha2 subunits of GABAA receptors in Wfs1-deficient mice. Neurosci Lett, 460, 138–142.
30.
ReimetsR, RaudS, LoometsM, et al. (2016). Variability in the effect of antidepressants upon Wfs1-deficient mice is dependent on the drugs' mechanism of actions. Behav Brain Res, 308, 53–63.
31.
RomagnoliM, Gomez-CabreraM-C, PerrelliM-G, et al. (2010). Xanthine oxidase-induced oxidative stress causes activation of NF-κB and inflammation in the liver of type I diabetic rats. Free Radic Biol Med, 49, 171–177.
32.
SedmanT, RünkorgK, KrassM, et al. (2016). Exenatide is an effective antihyperglycaemic agent in a mouse model of Wolfram syndrome 1. J Diabetes Res, 2016, 9239530.
33.
SelbyPL, ShearingPA, and MarshallSM. (1995). Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria. Diabet Med, 12, 240–243.
34.
SmuldersYM, BrouwerCB, and SilberbuschJ. (1999). Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus?. Diabetologia, 42, 382–383.
35.
StromTM, HörtnagelK, HofmannS, et al. (1998). Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet, 7, 2021–2028.
36.
SumboonnanondaA, VongjiradA, SuntornpochV, et al. (1997). Renal failure in two patients with Wolfram syndrome. J Pediatr Endocrinol Metab, 10, 645–651.
37.
TakedaK, InoueH, TanizawaY, et al. (2001). WFS1 (Wolfram syndrome 1) gene product: Predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet, 10, 477–484.
38.
TerasmaaA, SoometsU, OflijanJ, et al. (2011). Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. J Physiol Biochem, 67, 381–390.
39.
VisnapuuT, PlaasM, ReimetsR, et al. (2013). Evidence for impaired function of dopaminergic system in Wfs1-deficient mice. Behav Brain Res, 244, 90–99.
40.
YuX, LvJ, ZhuY, et al. (2013). Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress. PLoS One, 8, e54265.
41.
ZaguraM, KalsJ, KilkK, et al. (2015). Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease. Hypertens Res, 38, 840–846.
42.
ZalsmanG, MannMJ, HuangY, et al. (2009). Wolframin gene H611R polymorphism: No direct association with suicidal behavior but possible link to mood disorders. Prog Neuropsychopharmacol Biol Psychiatry, 33, 707–710.
43.
ZatykaM, Da Silva XavierG, BellomoEA, et al. (2015). Sarco(endo)plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression. Hum Mol Genet, 24, 814–827.
44.
ZatykaM, RickettsC, da Silva XavierG, et al. (2007). Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress. Hum Mol Genet, 17, 190–200.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
